-
-
-
-
-
-
-
Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Protagonist Therapeutics (PTGX) and Takeda (TAK) Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
-
-
-
-
-
-
-
Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Protagonist Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
After-Hours Stock Movers 04/25: O-I Glass, Cadence Design Gain on Earnings; Universal Health Falls (more...)
-
-
-
-
-
-
-
Protagonist Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Protagonist Therapeutics Reports Third Quarter 2019 Financial Results
-
1,216,126 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

